Abilify drug marketing charges settled with Florida, 42 states
Florida and 42 other states announced Thursday a $19.5 million settlement with Bristol-Myers Squibb Co. related to the alleged improper marketing of the drug Abilify to certain elderly patients and children.
“With this multistate settlement, consumers will be armed with better information about medication that could endanger their health,” Florida Attorney General Pam Bondi said in a statement.
Abilify, the brand name for the prescription drug aripiprazole, was initially approved for treating schizophrenia, officials noted.
A complaint by Florida officials alleged the company promoted Abilify for use in elderly patients with symptoms consistent with dementia and Alzheimer’s disease despite a lack of federal approval for those uses. In 2006, Abilify received a boxed warning that such patients who are treated with antipsychotic drugs have an increased risk of death, state officials said.
Read more: http://protectingyourpocket.blog.palmbeachpost.com/2016/12/08/abilify-drug-marketing-charges-settled-with-florida-42-states/